Results 21 to 30 of about 5,985 (143)

From efficacy to effectiveness: a comprehensive framework for monitoring, evaluating and optimizing seasonal malaria chemoprevention programmes. [PDF]

Malar J
Background Seasonal Malaria Chemoprevention (SMC) is a highly effective intervention for preventing malaria, particularly in areas with highly seasonal transmission.
de Cola MA, Chestnutt EG, Richardson S, Baudry M, Nnaji C, Ibinaiye T, Moukénet A, Rotimi K, Sawadogo B, Okafor J, Compaoré CS, Oguoma C, Rassi C, Roca-Feltrer A.   +13 more
europepmc   +4 more sources

Plasmodium falciparum dhps and dhfr markers of resistance to sulfadoxine-pyrimethamine five years (2016-2020) after the implementation of seasonal malaria chemoprevention in Cameroon. [PDF]

Wellcome Open Res
Background Antimalarial drug resistance is a major challenge in the fight against malaria. Cameroon implemented seasonal malaria chemoprevention (SMC) with sulfadoxine–pyrimethamine and amodiaquine (SPAQ) to over 1.5 million children aged 3–59 months ...
Tchuenkam PVK, Ngum LN, Ali IM, Chedjou JPK, Nji AM, Netongo PM, Ngwafor R, Niba PTN, Tah CF, Nana WD, Ekoyol G, Bigoga JD, Ashu DF, Tume CB, Mbacham WF.   +14 more
europepmc   +3 more sources

Prevalence of asymptomatic parasitaemia among household members of children under seasonal malaria chemoprevention coverage and comparison of the performance of standard rapid diagnostic tests versus ultrasensitive RDT for the detection of asymptomatic parasitaemia in Nanoro, Burkina Faso. [PDF]

Parasitol Res
Asymptomatic carriers of Plasmodium falciparum represent important parasite reservoirs maintaining malaria transmission in the community. This study aimed on the one hand to screen the other household members living with children under seasonal malaria ...
Kambou SAE, Millogo KS, Sondo P, Kabore B, Kouevi AFC, Bouda I, Rouamba T, Derra K, Tahita MC, Ilboudo H, Rouamba E, Tougri G, Otienoburu SD, Dhorda M, Bamba S, Guerin PJ, Tinto H.   +16 more
europepmc   +3 more sources

A hybrid effectiveness-implementation study protocol to assess the effectiveness and chemoprevention efficacy of implementing seasonal malaria chemoprevention in five districts in Karamoja region, Uganda. [PDF]

Gates Open Res, 2023
Background The World Health Organization (WHO) recommends seasonal malaria chemoprevention (SMC) with sulfadoxine-pyrimethamine and amodiaquine (SPAQ) for children aged 3 to 59 months, living in areas where malaria transmission is highly seasonal ...
Kajubi R, Ainsworth J, Baker K, Richardson S, Bonnington C, Rassi C, Achan J, Magumba G, Rubahika D, Nabakooza J, Tibenderana J, Nuwa A, Opigo J.   +12 more
europepmc   +4 more sources

Understanding and maximising the community impact of seasonal malaria chemoprevention in Burkina Faso (INDIE-SMC): study protocol for a cluster randomised evaluation trial. [PDF]

BMJ Open
Introduction Seasonal malaria chemoprevention (SMC) involves repeated administrations of sulfadoxine-pyrimethamine plus amodiaquine to children below the age of 5 years during the peak transmission season in areas of seasonal malaria transmission.
Moreno M, Barry A, Gmeiner M, Yaro JB, Sermé SS, Byrne I, Ramjith J, Ouedraogo A, Soulama I, Grignard L, Soremekun S, Koele S, Ter Heine R, Ouedraogo AZ, Sawadogo J, Sanogo E, Ouedraogo IN, Hien D, Sirima SB, Bradley J, Bousema T, Drakeley C, Tiono AB.   +22 more
europepmc   +4 more sources

Seasonal malaria chemoprevention in northern Mozambique: a cost-effectiveness analysis. [PDF]

Malar J
Abstract Background Malaria is endemic in Mozambique and one of the leading causes of death in children under 5 years old. In 2020 the country adopted the WHO-recommended seasonal malaria chemoprevention (SMC) strategy and delivered the intervention in all 23 districts of Nampula province between January and April ...
Canana N, Tarquino IAP, Enosse S, Baker K, Rodrigues M, Rassi C, Chauhan AS, Nnaji C, Candrinho B, Maffioli EM.   +9 more
europepmc   +5 more sources

Seasonal malaria chemoprevention: drug design and selection.

The Lancet Global Health
I. Zongo, Y. Compaoré
semanticscholar   +4 more sources

Predictors of caregiver adherence to administration of amodiaquine during delivery of seasonal malaria chemoprevention in Nigeria, Burkina Faso, Chad, and Togo [PDF]

Malaria Journal, 2023
Background Malaria is the leading cause of morbidity and mortality among infants and children under-five in sub-Saharan Africa. In the Sahel, seasonal malaria chemoprevention (SMC) is delivered door-to-door in monthly cycles.
Taiwo Ibinaiye, Olusola Oresanya, Chibuzo Oguoma, Adaeze Aidenagbon, Olabisi Ogunmola, C. Rassi, S. Richardson   +6 more
semanticscholar   +2 more sources

Adaptation of lot quality assurance sampling to monitor seasonal malaria chemoprevention delivery performance. [PDF]

Trans R Soc Trop Med Hyg
Malaria Consortium supports delivery of seasonal malaria chemoprevention (SMC) to children ages 3–59 months using sulfadoxine–pyrimethamine plus amodiaquine.
Richardson S, Ibinaiye T, Oresanya O, Oguoma C, Okoronkwo C, Shekarau E, Sprague D, Baker K, de Cola MA, Roca-Feltrer A, Nnaji C, Rassi C.   +11 more
europepmc   +2 more sources

Barriers to the quality delivery of seasonal malaria chemoprevention in Chad and Burkina Faso: a qualitative exploration of caregivers and community distributors' perspectives. [PDF]

Malar J
Background Recommended since 2012 by the World Health Organization (WHO), seasonal malaria chemoprevention (SMC) is a community-based intervention to prevent malaria in children in African regions where malaria transmission follows a seasonal pattern ...
Lasmi K, Elimian K, Donovan L, Tounaikok N, Traoré A, Gils T, Rassi C, Marasciulo M, Richardson S, Tougri G, Diar MSI, Baker K.   +11 more
europepmc   +2 more sources